Cardiovascular Disease in COVID-19 Patients in Wuhan, China
Studies of COVID-19 patients in Wuhan, China, highlight the significant impact of cardiovascular conditions on patient outcomes. Research indicates that pre-existing cardiovascular disease is a prevalent comorbidity that increases the likelihood of severe SARS-CoV-2 infection. Furthermore, cardiac injury is common among hospitalized COVID-19 patients and is strongly associated with a significantly higher risk of mortality.
0
2
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Disability Studies
Social Science
Empirical Science
Science
Learn After
Cardiovascular Disease in COVID-19 Patients in Wuhan, China: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Cardiovascular Disease in COVID-19 Patients in Wuhan, China: Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
Cardiovascular Disease in COVID-19 Patients in Wuhan, China: Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China